Thus, understanding the molecular and cellular mechanisms of the dynamics of pathological tau degradation or clearance in AD will immensely benefit understanding the basics of tau degradation and its dysfunction in more than twenty tauopathies and eventually develop novel effective therapeutic strategies. The gene discussed is MAPT; the disease is Alzheimer disease.